These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2165076)

  • 1. [Efficacy and tolerance of low molecular weight heparin in the prevention of deep venous thrombosis during non-emergent total hip arthroplasty. A prospective, multicenter trial].
    Simon P; Kindermans A; Kempf JF; Postel M
    J Chir (Paris); 1990 May; 127(5):252-7. PubMed ID: 2165076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of deep-vein thrombosis and pulmonary embolism after total hip replacement. Comparison of low-molecular-weight heparin and unfractionated heparin.
    Eriksson BI; Kälebo P; Anthymyr BA; Wadenvik H; Tengborn L; Risberg B
    J Bone Joint Surg Am; 1991 Apr; 73(4):484-93. PubMed ID: 2013587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug; 151(8):1621-4. PubMed ID: 1714709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.
    Hull R; Raskob G; Pineo G; Rosenbloom D; Evans W; Mallory T; Anquist K; Smith F; Hughes G; Green D
    N Engl J Med; 1993 Nov; 329(19):1370-6. PubMed ID: 8413432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of enoxaparine in preventing deep venous thrombosis following total hip prosthesis. Randomized multicenter prospective trial].
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weil D; Butel J
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():215-8. PubMed ID: 2852830
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic agents for venous thrombosis in elective hip surgery. Meta-analysis of studies using venographic assessment.
    Mohr DN; Silverstein MD; Murtaugh PA; Harrison JM
    Arch Intern Med; 1993 Oct; 153(19):2221-8. PubMed ID: 8215725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
    Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
    J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical diagnosis of deep venous thrombosis after hip replacement surgery].
    Andreassen G; Dahl OE
    Tidsskr Nor Laegeforen; 1997 May; 117(14):2026-7. PubMed ID: 9235679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
    Hamulyák K; Lensing AW; van der Meer J; Smid WM; van Ooy A; Hoek JA
    Thromb Haemost; 1995 Dec; 74(6):1428-31. PubMed ID: 8772214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily dosing of enoxaparin (a low molecular weight heparin) in prevention of deep vein thrombosis after total hip replacement.
    Planès A; Vochelle N; Fagola M; Bellaud M; Feret J; Salzard C; Planès M
    Acta Chir Scand Suppl; 1990; 556():108-15. PubMed ID: 1963015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis prophylaxis with low molecular weight heparin in total hip replacement.
    Eriksson BI; Zachrisson BE; Teger-Nilsson AC; Risberg B
    Br J Surg; 1988 Nov; 75(11):1053-7. PubMed ID: 2463035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis prevention after total hip arthroplasty: a prospective, randomized trial comparing a mobile compression device with low-molecular-weight heparin.
    Colwell CW; Froimson MI; Mont MA; Ritter MA; Trousdale RT; Buehler KC; Spitzer A; Donaldson TK; Padgett DE
    J Bone Joint Surg Am; 2010 Mar; 92(3):527-35. PubMed ID: 20194309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phlebographic findings in venous thrombosis following total hip replacement.
    Kälebo P; Anthmyr BA; Eriksson BI; Zachrisson BE
    Acta Radiol; 1990 May; 31(3):259-63. PubMed ID: 2167109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the efficacy and tolerance of Kabi 2165 and standard heparin in the prevention of deep venous thrombosis in total hip prosthesis].
    Barre J; Pfister G; Potron G; Droulle C; Baudrillard JC; Barbier P; Kher A
    J Mal Vasc; 1987; 12 Suppl B():90-5. PubMed ID: 2834500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin decreases proximal and distal deep venous thrombosis following total knee arthroplasty. A meta-analysis of randomized trials.
    Howard AW; Aaron SD
    Thromb Haemost; 1998 May; 79(5):902-6. PubMed ID: 9609217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low molecular heparin in prevention of thrombosis in orthopedic surgery].
    Jensen HP; Borris LC; Lassen MR; Sørensen JV; Rahr HB; Christiansen HM; Ejstrud P
    Ugeskr Laeger; 1993 Apr; 155(15):1109-15. PubMed ID: 8387708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.